Log in
Enquire now

List of MorphoSys patents

List of MorphoSys patents
List of Athenex patents
List of BioNTech patents
List of CellPly patents
List of companies in The Junction's investment portfolio
List of Rutgers, the State University of New Jersey patents
Patents where
Current Assignee
Name
is
MorphoSysMorphoSys
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9758590 Anti-CD38 human antibodies and uses thereof

Patent 9758590 was granted and assigned to MorphoSys on September, 2017 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
9758590
September 12, 2017
‌
US Patent 7264963 Protein(poly)peptide libraries

Patent 7264963 was granted and assigned to MorphoSys on September, 2007 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
7264963
September 4, 2007
‌
US Patent 11472880 Humanized antibodies for CD3

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11472880
October 18, 2022
‌
US Patent 11059902 Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38

Patent 11059902 was granted and assigned to MorphoSys on July, 2021 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11059902
July 13, 2021
‌
US Patent 10184005 Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38

Patent 10184005 was granted and assigned to MorphoSys on January, 2019 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10184005
January 22, 2019
‌
US Patent 11542329 Antibodies targeting Glycoprotein VI

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11542329
January 3, 2023
‌
US Patent 9193799 Fully human therapeutic antibodies specific for human CD38

Patent 9193799 was granted and assigned to MorphoSys on November, 2015 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
9193799
November 24, 2015
‌
US Patent 11591406 Treatment for multiple myeloma (MM)

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11591406
February 28, 2023
‌
US Patent 11618789 Clinical assessment of M-protein response in multiple myeloma

Patent 11618789 was granted and assigned to MorphoSys on April, 2023 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11618789
April 4, 2023
‌
US Patent 11352620 Peptide libraries

Patent 11352620 was granted and assigned to MorphoSys on June, 2022 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11352620
June 7, 2022
‌
US Patent 10919955 Rodent combinatorial antibody libraries

Patent 10919955 was granted and assigned to MorphoSys on February, 2021 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10919955
February 16, 2021
‌
US Patent 11014978 Canine antibody libraries

Patent 11014978 was granted and assigned to MorphoSys on May, 2021 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11014978
May 25, 2021
‌
US Patent 10308722 Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide

Patent 10308722 was granted and assigned to MorphoSys on June, 2019 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10308722
June 4, 2019
‌
US Patent 9624293 Collection and methods for its use

Patent 9624293 was granted and assigned to MorphoSys on April, 2017 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
9624293
April 18, 2017
‌
US Patent 11254734 Fab molecules with a rodent hinge region and a non-rodent CH1 region

Patent 11254734 was granted and assigned to MorphoSys on February, 2022 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11254734
February 22, 2022
‌
US Patent 11352423 Anti-CD19 antibody formulations

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
11352423
June 7, 2022
‌
US Patent 9689014 Use of lysozyme as a tag

Patent 9689014 was granted and assigned to MorphoSys on June, 2017 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
9689014
June 27, 2017
‌
US Patent 9856316 Antibodies targeting M-CSF

Patent 9856316 was granted and assigned to MorphoSys on January, 2018 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
9856316
January 2, 2018
‌
US Patent 10822604 Peptide libraries

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10822604
November 3, 2020
‌
US Patent 8206977 Tricistronic vectors and uses therefor

Patent 8206977 was granted and assigned to MorphoSys on June, 2012 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
8206977
June 26, 2012
‌
US Patent 10647757 Collection and methods for its use

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10647757
May 12, 2020
‌
US Patent 10913792 Treatment for rheumatoid arthritis

Patent 10913792 was granted and assigned to MorphoSys on February, 2021 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10913792
February 9, 2021
‌
US Patent 10273285 Fusion proteins and uses thereof

Patent 10273285 was granted and assigned to MorphoSys on April, 2019 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10273285
April 30, 2019
‌
US Patent 10774154 Complex-specific antibodies and antibody fragments and its use

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10774154
September 15, 2020
‌
US Patent 10533057 Treatment for multiple myeloma (MM)

Patent 10533057 was granted and assigned to MorphoSys on January, 2020 by the United States Patent and Trademark Office.

MorphoSys
MorphoSys
MorphoSys
MorphoSys
United States Patent and Trademark Office
United States Patent and Trademark Office
10533057
January 14, 2020
Results per page:
31 results
0 selected
31 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us